Fernández I M, Golding H, Benaissa-Trouw B J, de Vos N M, Harmsen M, Nottet H S, Golding B, Puijk W C, Meloen R H, Snippe H, Kraaijeveld C A
Eijkman-Winkler Institute for Microbiology, Infectious Diseases and Inflammation, University Hospital, Utrecht, The Netherlands.
Vaccine. 1998 Dec;16(20):1936-40. doi: 10.1016/s0264-410x(98)00128-5.
A colinearly synthesized peptide consisting of a H-2d restricted T-helper cell epitope of Semliki Forest virus (SFV) and triple repeats of sequence GPGRAF, derived from the V3 domain of HIV-1 strains, was used to immunize BALB/c (H-2d) mice. Pepscan analysis of sera from peptide-immunized mice revealed that the chimaeric peptide GREKFTIRPHYGKEIGPGRAFGPGRAFGPGRAF contains three distinct antibody-reactive sequences GREKFTIR, PHYGKEI and GPGRAF. The chimaeric peptide evoked HIV-1 IIIb neutralizing antibodies in serum as measured in vitro by reduction of syncytia formation and reduction of p24 production as well. So, the T-helper cell epitope of SFV provided help to a small linear neutralization epitope of HIV-1 strains. Interestingly, the T-helper cell epitope alone might induce antibodies cross-reactive with HIV-1 IIIb specific peptide GPGRAFVTIGK which shows some homology (residues underlined) with the antibody-reactive sequence GREKTIR of SFV.